Stylus Medicine, Inc. ("Stylus"), a biotechnology company dedicated to developing transformative in vivo genetic medicines, today emerges from stealth with $85 million in financing. Stylus' funding ...

Industry layoffs continue to accelerate, this time hitting RA Capital’s biotech incubator, according to Stat News ...

The Department of Immunology and Inflammation’s mission is to integrate discovery science with clinical medicine to prevent or treat inflammatory and haematological conditions. We focus on discovering ...